The Cleveland Cavaliers Couldn't Admit This Simple Fact After Getting Crushed by the...
The Trump-Jaxson Dart Story Was Already Dead, but the Giants Made Sure to...
The Sign of Trouble for the James Talarico Campaign Is How the Press...
Jefferson on How to Restore the Republic
Pollsters Are Underestimating Trump 10 Years Later. What Might It Mean for the...
The Push by Democrats to Ban One of the Commonly Owned Handguns in...
How AI Threatens to Destroy the Core Self and How to Fight Back
Mission Laundering: What the OpenAI Verdict Didn't Resolve
Germany's Bureaucracy Crisis: How Red Tape Is Costing the Economy €146 Billion a...
The Real AI Risk Isn’t Regulation. It’s Strategic Blindness.
America Is Sleepwalking Toward Q-Day While Cybercriminals Prepare for the Future
Putin’s Efforts to Subvert Armenia’s Elections Can Harm US Interests
The Deal to Keep the Islamic Republic Alive
US-UAE Relations: Dubai Remains a Pillar of Stability in the Middle East
FBI Arrests Man Accused of Threatening to Kill ICE Agents and Their Families...
Tipsheet

Media Outlets Openly Report That the FDA's Latest Decision Was Political

Media Outlets Openly Report That the FDA's Latest Decision Was Political

The Food and Drug Administration on Thursday approved the first over-the-counter birth control pill in the U.S.

In early 2024, Perrigo’s once-a-day Opill, a progestin-only pill, will be available at drug stores, supermarkets, and online.

Advertisement

“Today’s approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research, on Thursday. “When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy.”

There is no age restriction on the pill, despite concerns over correct usage and possible health hazards associated with it.

Seventeen advisers to the FDA voted unanimously in May to make Opill available over the counter despite concerns the agency raised about data Perrigo submitted with its application, including a study showing that many participants reported taking more pills than they were dispensed. The company said it couldn’t explain the discrepancy.

The agency questioned whether younger people and people with limited literacy could follow the dosing directions and said researchers likely used methods that exaggerated positive results. Perrigo said standards met or exceeded those used in other studies exploring over-the-counter drug adherence. (WSJ)

Kristan Hawkins of Students for Life said the news should mean pro-choice advocates won’t need abortions anymore, according to their own arguments. 

Advertisement

Related:

FDA

Others pointed out that media reports are not hiding the fact that it was a political decision. 

Health experts, citing the pill’s lengthy record of safety and effectiveness, have pushed for a nonprescription pill for years, but their campaign took on new urgency after the Supreme Court last year struck down the fundamental right to abortion established by Roe v. Wade. (WaPo)

Since the Supreme Court overturned the national right to an abortion last year, the accessibility of contraception has become an increasingly urgent issue. (NYT)

Though the drug itself and the campaign for its approval go back decades, pressure on the Biden administration to approve a hormonal over-the-counter birth control option increased after the fall of Roe v. Wade last year. (Politico)


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos